Insiders who reported open-market trades in the last 12 months at the companies Marshall Fordyce files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
William D. Turner - $1.45M in VERA purchases and sales in the last 12 months
Joseph R. Young - $567K in VERA purchases and sales in the last 12 months
Sean Grant - $208K in VERA purchases and sales in the last 12 months
David Lee Johnson - $108K in VERA purchases and sales in the last 12 months
Jason S. Carter - $107K in VERA purchases and sales in the last 12 months
Robert Brenner - $90K in VERA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Marshall Fordyce is a corporate insider, tracked as PRESIDENT AND CEO, Director of Vera Therapeutics, Inc. (VERA). InsiderAlpha holds 15 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Marshall Fordyce submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Marshall Fordyce been buying or selling stock?
Recorded transactions: 0 open-market purchases and 45 open-market sales ($12.50M) across all tracked filings.
Marshall Fordyce is PRESIDENT AND CEO, Director of Vera Therapeutics, Inc. (VERA). 15 SEC Form 4 filings on record going back to 2024, most recently on 17 September 2026. Most recent open-market trade: sold $684K of VERA on 17 September 2026. Lifetime open-market sales: $12.50M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Marshall Fordyce.
InsiderAlpha's records for Marshall Fordyce go back to 2024: 15 primary Form 4 filings, an average of 5.0 per year. 98 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
